Posted inCardiology Clinical Updates
Cangrelor versus Crushed Ticagrelor in Acute Myocardial Infarction Complicated by Cardiogenic Shock: Insights from the DAPT-SHOCK-AMI Randomised, Double-Blind Trial
This review synthesizes evidence from the DAPT-SHOCK-AMI trial and related studies comparing intravenous cangrelor to crushed oral ticagrelor in AMI complicated by cardiogenic shock, highlighting platelet inhibition efficacy, clinical outcomes, and implications for P2Y12 inhibitor strategies in high-risk patients.
